DK1438970T3 - Fremgangsmåde til at inhibere HIV-associerede sygdomme ved hjælp af monoklonale antistoffer rettet mod sig-selv-rettede cytotoksiske celler - Google Patents

Fremgangsmåde til at inhibere HIV-associerede sygdomme ved hjælp af monoklonale antistoffer rettet mod sig-selv-rettede cytotoksiske celler

Info

Publication number: DK1438970T3
Authority: DK; Denmark
Prior art keywords: self; monoclonal antibodies; associated diseases; cytotoxic cells; inhibiting hiv
Prior art date: 1993-03-19

Application number

DK04101437T

Other languages

English (en)

Inventor

D Allen Allen

Original Assignee

D Allen Allen

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-03-19

Filing date

1994-03-21

Publication date

2008-12-15

1994-03-21 Application filed by D Allen Allen filed Critical D Allen Allen

2008-12-15 Application granted granted Critical

2008-12-15 Publication of DK1438970T3 publication Critical patent/DK1438970T3/da

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2815—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against CD8
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2821—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
- C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2839—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
- C07K16/2845—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta2-subunit-containing molecules, e.g. CD11, CD18
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
AIDS & HIV (AREA)
Bioinformatics & Cheminformatics (AREA)
Tropical Medicine & Parasitology (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK04101437T 1993-03-19 1994-03-21 Fremgangsmåde til at inhibere HIV-associerede sygdomme ved hjælp af monoklonale antistoffer rettet mod sig-selv-rettede cytotoksiske celler DK1438970T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US3340593A	1993-03-19	1993-03-19
US16575193A	1993-12-13	1993-12-13
CA002425086A CA2425086A1 (en)	1993-03-19	2003-04-10	Method of increasing the delayed-type hypersensitivity response by infusing lfa-1 specific antibodies

Publications (1)

Publication Number	Publication Date
DK1438970T3 true DK1438970T3 (da)	2008-12-15

Family

ID=34084057

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK04101437T DK1438970T3 (da)	1993-03-19	1994-03-21	Fremgangsmåde til at inhibere HIV-associerede sygdomme ved hjælp af monoklonale antistoffer rettet mod sig-selv-rettede cytotoksiske celler

Country Status (11)

Country	Link
US (1)	US5424066A (da)
EP (2)	EP1438970B1 (da)
AT (2)	ATE408418T1 (da)
AU (1)	AU684074B2 (da)
CA (2)	CA2156495C (da)
DE (2)	DE69435142D1 (da)
DK (1)	DK1438970T3 (da)
ES (2)	ES2219647T3 (da)
HK (1)	HK1067958A1 (da)
PT (2)	PT690725E (da)
WO (1)	WO1994021295A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6534057B2 (en)	1993-03-19	2003-03-18	Allen D. Allen	Method increasing the delayed-type hypersensitivity response by infusing LFA-1-specific antibodies
US5651970A (en) *	1993-03-19	1997-07-29	Allen; Allen D.	Method for inhibiting disease associated with the human immunodeficiency virus through the use of monoclonal antibodies directed against anti-self cytotoxic T-lymphocytes or their lytics
AU2248395A (en) *	1994-04-15	1995-11-10	Allen D. Allen	Method of treating hiv infection using antibodies against cytotoxic t-cells and thymic humoral factor
CA2191333C (en) *	1995-04-14	2006-08-01	Hirofumi Moriyama	Phosphor with afterglow characteristic
WO1996039187A1 (en) *	1995-06-06	1996-12-12	Allen D Allen	Method for treating molluscum contagiosum resulting from hiv infection
AU6091696A (en) *	1995-06-07	1996-12-30	Connective Therapeutics Inc.	Treating immune deficiency diseases using t cell receptor pe ptides
WO1998037917A1 (en) *	1997-02-28	1998-09-03	Enzo Therapeutics, Inc., A Fully Owned Subsidiary Of Enzo Biochem, Inc.	Novel processes implementing selective immune down regulation (sidr)
US20030170258A1 (en) *	2001-05-09	2003-09-11	Enzo Therapeutics, Inc.	Novel processes implementing selective immune down regulation (SIDR)
US6919077B2 (en) *	2002-09-27	2005-07-19	Aids Research, Llc	LFA-1 alpha subunit antibodies and methods of use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5002869A (en) *	1987-11-02	1991-03-26	Dana-Farber Cancer Institute	Monoclonal antibody specific to a novel epitope of the LFA-1 antigen of human T lymphocytes

1994
- 1994-03-21 PT PT94912826T patent/PT690725E/pt unknown
- 1994-03-21 AT AT04101437T patent/ATE408418T1/de active
- 1994-03-21 AU AU65221/94A patent/AU684074B2/en not_active Ceased
- 1994-03-21 DE DE69435142T patent/DE69435142D1/de not_active Expired - Lifetime
- 1994-03-21 EP EP04101437A patent/EP1438970B1/en not_active Expired - Lifetime
- 1994-03-21 ES ES94912826T patent/ES2219647T3/es not_active Expired - Lifetime
- 1994-03-21 DK DK04101437T patent/DK1438970T3/da active
- 1994-03-21 ES ES04101437T patent/ES2314341T3/es not_active Expired - Lifetime
- 1994-03-21 AT AT94912826T patent/ATE267019T1/de not_active IP Right Cessation
- 1994-03-21 DE DE69433789T patent/DE69433789T2/de not_active Expired - Lifetime
- 1994-03-21 EP EP94912826A patent/EP0690725B1/en not_active Expired - Lifetime
- 1994-03-21 CA CA002156495A patent/CA2156495C/en not_active Expired - Lifetime
- 1994-03-21 WO PCT/US1994/003055 patent/WO1994021295A1/en active IP Right Grant
- 1994-03-21 PT PT04101437T patent/PT1438970E/pt unknown
- 1994-09-07 US US08/302,113 patent/US5424066A/en not_active Expired - Lifetime
2003
- 2003-04-10 CA CA002425086A patent/CA2425086A1/en not_active Abandoned
2005
- 2005-01-08 HK HK05100178A patent/HK1067958A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP1438970A3 (en)	2004-12-08
EP0690725A1 (en)	1996-01-10
DE69433789T2 (de)	2005-06-23
US5424066A (en)	1995-06-13
CA2156495A1 (en)	1994-09-29
CA2425086A1 (en)	2004-10-10
EP1438970A2 (en)	2004-07-21
EP0690725A4 (en)	1997-09-03
AU6522194A (en)	1994-10-11
DE69433789D1 (de)	2004-06-24
ATE267019T1 (de)	2004-06-15
DE69435142D1 (de)	2008-10-30
CA2156495C (en)	2008-11-18
PT1438970E (pt)	2008-12-26
PT690725E (pt)	2004-10-29
EP1438970B1 (en)	2008-09-17
WO1994021295A1 (en)	1994-09-29
ATE408418T1 (de)	2008-10-15
ES2314341T3 (es)	2009-03-16
ES2219647T3 (es)	2004-12-01
AU684074B2 (en)	1997-12-04
HK1067958A1 (en)	2005-04-22
EP0690725B1 (en)	2004-05-19

Publication	Publication Date	Title
HK1067958A1 (en)	2005-04-22	Methods for inhibiting hiv associated disease using monoclonal antibodies directed against anti-selfcytotoxic t-cells
ATE373712T1 (de)	2007-10-15	Natürlicher menschlicher antikörper
DK0853633T3 (da)	2003-08-04	Humant monoklonalt antistof imod hepatitis B virus overfladeantigen (HBVsAg)
AU4985496A (en)	1996-09-04	Administration of a cyclosporine-specific monoclonal antibody that cross-reacts with hiv-1 p24 gag to treat hiv infection
CA2192512A1 (en)	1998-06-10	Nm03 antibody materials and methods
BR0312808A (pt)	2005-04-19	Proteìna de fusão igg fc/hiv-gp120/c3d
SE9000333D0 (sv)	1990-01-31	Monoklonal antikropp
DE69128108D1 (de)	1997-12-11	Monoklonaler Antikörper gegen HTLV-III (Stamm MN)
ATE125870T1 (de)	1995-08-15	Hiv-spezifische monoklonale antikörper und hybridome zu ihrer herstellung.
MX9301858A (es)	1994-03-31	Anticuerpos monoclonales neutralizantes de hiv-humano recombinante para prevencion y tratamiento de infeccion hiv.
DE69213325D1 (de)	1996-10-10	Gegen das menschliche Immunschwäche-Virus gerichtetes Immunpräparat
ES2000615A6 (es)	1988-03-01	Procedimiento para la preparacion del anticuerpo monoclonal designado como mak 436-15 del isotipo igg3"
CA2160696A1 (en)	1994-10-27	Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
AU4959193A (en)	1993-11-08	High affinity, strongly neutralizing monoclonal antibodies against the CD-4 binding site of GP120 of human immunodeficiency virus
AU627540B2 (en)	1992-08-27	Drug for the treatment or prevention by passive immunization, of the hiv-infection and process for preparation thereof
ATE128733T1 (de)	1995-10-15	Monoklonale antikörper gegen hiv gp120.
DE68926454D1 (de)	1996-06-13	Gegen hiv 1 gp48 spezifische antikörper
ES2013665A6 (es)	1990-05-16	Procedimiento para preparar un anticuerpo monoclonal humano y metodo de uso.
CA2239596A1 (en)	1997-06-26	Sugar-chain-recognizing antibodies and remedies for hiv infectious diseases